Table 5 Antimicrobial susceptibility testing of the pathogenic strain EPL 0201

β-Lactams

Cefazolin

30

17.66

R

Cephalothin

30

15.98

I

Cefotaxime

30

15.43

R

Ceftriaxone

30

31.02

S

Ceftazidime

30

20.26

I

Cefoperazone

75

26.74

S

Cefepime

30

21.26

S

Cefoxitin

30

15.68

R

Amoxicillin

10

11.52

R

Azlocillin

75

16.36

R

Piperacillin

100

21.28

S

Mezlocillin

75

20.64

S

Ticarcillin

75

23.26

S

Ampicillin

10

10.16

R

Penicillin

10

8.66

R

Imipenem

10

29.72

S

Meropenem

10

31.72

S

Aminoglycosides

Kanamycin

30

17

I

Spectinomycin

100

15.26

I

Neomycin

30

19.12

I

Streptomycin

10

6.35

R

Amikacin

30

13.88

R

Gentamicin

10

16.71

S

Tobramycin

10

15.64

S

Glycopeptides

Teicoplanin

30

8.67

R

Vancomycin

30

10.65

R

Quinolones

Nalidixic acid

30

36.51

S

Ciprofloxacin

5

18.68

I

Levofloxacin

5

25.03

S

Enrofloxacin

5

34.9

S

Norfloxacin

10

11.66

R

Ofloxacin

5

15.54

I

Chloramphenicols

Chloramphenicol

30

16.98

I

Macrolides

Azithromycin

15

31.37

S

Erythromycin

15

29.06

S

Roxithromycin

15

23.01

S

Midecamycin

15

24.43

S

Claricid

15

23.16

S

Nitrofurans

Furazolidone

300

21.5

S

Lincosamides

Lincomycin

2

10.02

R

Clindamycin

2

13.96

I

Sulfonamides

Trimethoprim

23.75

6.35

R

Tetracyclines

Tetracycline

30

15.04

I

Doxycycline

30

18.86

I

Minocycline

30

32.77

S

Others

Rifampin

5

11.98

R

Methoxyamine

5

6.35

R

Polymyxin B

300

11.03

I